The Supreme Court has ruled against generic drugmaker Mylan Inc. and other firms in their challenge of Teva Pharmaceutical Industries' patents for a blockbuster multiple sclerosis drug. The justices ruled 7-2 that a federal appeals court wrongly overturned five of Teva's patents for the drug Copaxone, which generates about (Dollar) 4 billion in annual sales for Teva. The majority told a lower court to reconsider a ruling invalidating the patents. The ...
Read More
You have just read an article categorized health
titled Mylan Loses Court Fight Over Multiple Sclerosis Drug.
Written by:
editor -
Thursday, January 22, 2015
There are currently no comments for "Mylan Loses Court Fight Over Multiple Sclerosis Drug"
Post a Comment